Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

Allen M. Spiegel, S. W. Rosen, B. D. Weintraub, S. P. Marynick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. The authors tested the effect of pyridoxine (300 mg-iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study.

Original languageEnglish (US)
Pages (from-to)686-688
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume46
Issue number4
StatePublished - 1978
Externally publishedYes

Fingerprint

Pyridoxine
Prolactin
Plasmas
Hyperprolactinemia
Nonpuerperal galactorrhea
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects. / Spiegel, Allen M.; Rosen, S. W.; Weintraub, B. D.; Marynick, S. P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 46, No. 4, 1978, p. 686-688.

Research output: Contribution to journalArticle

@article{3ef2ed4450f94cc39b852cd9ce2caf2b,
title = "Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects",
abstract = "Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. The authors tested the effect of pyridoxine (300 mg-iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study.",
author = "Spiegel, {Allen M.} and Rosen, {S. W.} and Weintraub, {B. D.} and Marynick, {S. P.}",
year = "1978",
language = "English (US)",
volume = "46",
pages = "686--688",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

AU - Spiegel, Allen M.

AU - Rosen, S. W.

AU - Weintraub, B. D.

AU - Marynick, S. P.

PY - 1978

Y1 - 1978

N2 - Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. The authors tested the effect of pyridoxine (300 mg-iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study.

AB - Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. The authors tested the effect of pyridoxine (300 mg-iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study.

UR - http://www.scopus.com/inward/record.url?scp=0018181205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018181205&partnerID=8YFLogxK

M3 - Article

C2 - 755053

AN - SCOPUS:0018181205

VL - 46

SP - 686

EP - 688

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -